Latest News and Press Releases

Engagement with FDA on GH001 IND complete response ongoingThe fully completed Open-Label Extension analysis confirms a 73% remission rate at 6 months with infrequent treatment visits and no...

Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The "Bipolar Disorder Market - A Global and Regional Analysis: Focus on Class Type and Country Analysis - Analysis and Forecast, 2025-2035" report has been...

FDA has cleared the new Magstim Rapid TMS system for research and clinical applications, now with FDA clearance in the U.S. for the treatment of pain.

PALM BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Worldwide, there is a rising demand for neuropsychiatric disorder treatments which is expected to fuel the global...

Unyte Health launches Rest and Restore Protocol™, a sound-based therapy to support nervous system regulation and ease effects of stress and trauma.

Apex Labs Granted Israel MoH Approval to Expand Phase 2b Macrodose Psilocybin PTSD Clinical Trial.

Les fonds permettront d’avancer dans la découverte de traitements potentiellement disruptifs, à action rapide, pour la dépression résistante aux traitements et d'autres troubles...

Proceeds to advance potentially disruptive, fast-acting therapeutics for treatment-resistant depression and other neuropsychiatric disordersFirst-in-class, non-addictive, non-hallucinogenic molecules...

Investment supports the development of first-in-class, non-addictive, non-hallucinogenic molecules with a non-synaptic target, differentiated from existing drugs First start-up company from Argobio’s...

Charlotte, NC, May 29, 2025 (GLOBE NEWSWIRE) -- Caring.com, a leading senior living referral service and the nation’s top site for care reviews, published the results of its 2025 Senior Mental...